Drug Type Mesenchymal stem cell therapy |
Synonyms Autologous adipose tissue-derived mesenchymal stem cells (R Bio), autologous adipose tissue derived mesenchymal stem cells (R Bio) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (EU) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Facial Hemiatrophy | Phase 2 | KR | 12 Oct 2022 | |
Thromboangiitis Obliterans | Phase 2 | KR | 12 Oct 2022 |